2023年6月23日

Yashoda醫院,與Elekta合作,一個瑞典的精確放射治療,介紹了後者的團結直線加速器係統先生在印度,癌症治療的一個重要的飛躍。的先進技術,結合磁共振成像(MRI)的精度與精確的輻射傳遞,放療設定了新的標準。團結直線加速器先生,Yashoda醫院成為第一個工廠在印度提供病人適應輻射療法是準確的,精確,並優化臨床結果,同時盡可能減少毒性。Manikandan巴拉——總經理Elekta印度和洲際高級副總裁說:“我們很高興將最先進的直線加速器,統一到印度。“這種創新技術代表了癌症治療的一個重要進步和演示了我們的承諾對改善病人的治療。我們堅信Elekta團結直線加速器先生將推動印度放射治療領域的新高度,導致改善治療結果。“Yashoda醫院,Elekta發射團結直線加速器先生在印度癌症死亡的第二大原因在印度心髒病後,構成了重大的健康挑戰。記錄從2018年到2020年,全國超過四百萬個癌症病例和225萬人死亡的疾病。作為癌症治療的領域是由技術,極大地影響了先生和可訪問性,進步的統一,upskilling直線加速器係統提高患者的治療效果和整體護理質量的關鍵。放射治療是腫瘤治療的重要組成部分,有超過一半的癌症患者需要治療。 Access to radiotherapeutic facilities is crucial, as radiation therapy is considered the most cost-effective form of therapy. Traditional LINAC systems separate the processes of imaging and radiation delivery. Patients undergo external imaging scans such as CT or MRI, and a treatment plan is crafted based on these images. This method, however, has limitations in visualising tumors and surrounding healthy tissues in detail. Recognised for its superior imaging of soft tissues compared to CT scans, MRI technology has revolutionised diagnostic radiology. The challenge lay in merging MRI with a linear accelerator for radiation therapy, which was previously deemed technically incompatible. Elekta’s scientists and engineers, however, have made a revolutionary breakthrough by successfully integrating the power of MRI with a precise linear accelerator into a single unit. This state-of-the-art machine harnesses the capabilities of both MRI technology and a linear accelerator to enable real-time, precise, and accurate radiation therapy. Dr GS Rao — Yashoda Hospitals Hyderabad Managing Director said: “MR-guided radiation therapy is now being utilized for various conditions, including benign and malignant brain tumors and cancers of Head & Neck, prostate, pancreas, lung, liver and rectum. It’s important to note that the specific applications of this technology are rapidly evolving as its capabilities continue to advance.”